Increased Fatty Acid Synthase Activity in Non-small Cell Lung Cancer Tissue Is a Weaker Predictor of Shorter Patient Survival than Increased Lipoprotein Lipase Activity-Reference-Cited by-同舟云学术

Increased Fatty Acid Synthase Activity in Non-small Cell Lung Cancer Tissue Is a Weaker Predictor of Shorter Patient Survival than Increased Lipoprotein Lipase Activity

Published:2010-08 Issue:6 Volume:41 Page:405-409
ISSN:0188-4409
Container-title:Archives of Medical Research
language:en
Short-container-title:Archives of Medical Research

Author:

Cerne Darko,Prodan Zitnik Irena,Sok Miha

Publisher

Elsevier BV

Subject

General Medicine

Reference25 articles.

1. De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy;Mashima;Br J Cancer,2009

2. Fatty acid synthase and cancer: new application of an old pathway;Kuhajda;Cancer Res,2006

3. Prognostic value of expression of FASE, HER-2/neu, bcl-2 and p53 in stage I non-small cell lung cancer;Wang;Zhonghua Zhong Liu Za Zhi,2004

4. High-level expression of fatty acid synthase in human prostate cancer tissues is linked to activation and nuclear localization of Akt/PKB;Van de Sande;J Pathol,2005

5. Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patients;Alò;Cancer,1996

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Triptolide Reduces Neoplastic Progression in Hepatocellular Carcinoma by Downregulating the Lipid Lipase Signaling Pathway;Cancers;2024-01-27

2. High-dose radiation-resistant lung cancer cells stored many functional lipid drops through JAK2/p-STAT3/FASN pathway;Journal of Cancer Research and Clinical Oncology;2023-08-09

3. AZ12756122, a novel fatty acid synthase inhibitor, decreases resistance features in EGFR-TKI resistant EGFR-mutated NSCLC cell models;Biomedicine & Pharmacotherapy;2022-12

4. Approaches to Measuring the Activity of Major Lipolytic and Lipogenic Enzymes In Vitro and Ex Vivo;International Journal of Molecular Sciences;2022-09-21

5. Targeting Cancer Metabolism and Current Anti-Cancer Drugs;Advances in Experimental Medicine and Biology;2021